Renada Jemese Scott Nash, FNP

Renada Nash practices at High Desert Medical Group in Lancaster, California.

Renada Nash's NPI, 1447903869, was assigned on January 27, 2022. Renada Nash holds California license 95019264.

Renada Nash's primary practice is High Desert Medical Group, at 43839 15th W St, Lancaster, CA 93534. The practice phone is (661) 945-5984.

Renada Nash's primary practice is High Desert Medical Group in Lancaster, California. The medical group on file is High Desert Medical Group. Dmand AI also links Renada Nash to 3 more group practices and clinics and 2 medical groups, each named with a free account. Renada Nash's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Renada Nash practices, 4 sites in all. Vendor and product names are available with a free account.

Family is Renada Nash's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Renada Nash is licensed in California.

Dmand AI lists acute sinusitis, acute skin infection, ankle or foot injury, asthma, chest wall injury, chronic obstructive pulmonary disease (COPD), conjunctivitis and contact dermatitis among the conditions Renada Nash treats.

CMS data shows 418 Medicare services from Renada Nash across 8 procedure codes in 2024, for 197 Medicare patients. Medicare paid $17,495 for them. Every service was in an office.

CMS counts 197 Medicare patients who saw Renada Nash in 2024. The largest group is 65 to 74, with 85 patients. 74% of them have high blood pressure, and 73% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Renada Nash's median patient age at 51, with 59% women.

In 2024, Renada Nash wrote 1,226 Medicare Part D claims for 699 patients. 95% of them were for generic drugs. CMS names the drug for 1,056 of them, across 23 drugs with 11 or more claims each, at $5,907 in total drug cost.

Renada Nash accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Renada Nash from 3 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $250.